Zhejiang Tianyu Pharmaceutical Co., Ltd.

FDA inspection history across 2 sites, 2015 to 2024

4
Form 483s
1
Warning letter
1
Close-out

Every document, by year

  • Form 483
  • Warning letter
  • Close-out

2015: one Form 483; 2019: one Form 483; 2022: one warning letter and one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015One Form 483, at Taizhou, China.
  2. 2019One Form 483, at Taizhou, China.
  3. 2019The longest 483 on file: 5 observations over 3 pages at Taizhou, China.
  4. 2022–24Two Form 483s and one warning letter, at Taizhou City, China and Taizhou, China.

Cited most

Across all Zhejiang Tianyu Pharmaceutical Co. observations on file

The complete Zhejiang Tianyu Pharmaceutical Co. file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Also: two documents not tied to a site.

Documents

6 on file, newest first
DateDocumentPrice
2024-11-29483 Form 483$99
2022-08-17Warning letter Warning letter$99
2022-03-04483 Form 483$99
2019-04-12483 Form 483$99
2015-06-12483 Form 483$99
UndatedClose-out Close-out letter$99

FEI number 3010972581 · most recent document Nov 29, 2024

About Zhejiang Tianyu Pharmaceutical Co., Ltd.

How many FDA Form 483s has Zhejiang Tianyu Pharmaceutical Co., Ltd. received?

FDA Intel has 4 Form 483s on file for Zhejiang Tianyu Pharmaceutical Co., Ltd.; the most recent is dated Nov 29, 2024.

When was Zhejiang Tianyu Pharmaceutical Co., Ltd. last inspected by FDA?

The most recent FDA inspection document on file for Zhejiang Tianyu Pharmaceutical Co., Ltd. is a Form 483 dated Nov 29, 2024, for the site in Taizhou, China.

What did FDA cite at Zhejiang Tianyu Pharmaceutical Co., Ltd.?

The regulations cited most in the observations on file for Zhejiang Tianyu Pharmaceutical Co., Ltd. are 21 CFR 211.67 (Equipment cleaning and maintenance), 3 times; 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.122 (Materials examination and usage criteria), 1 time.

Has Zhejiang Tianyu Pharmaceutical Co., Ltd. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Zhejiang Tianyu Pharmaceutical Co., Ltd.; the most recent is dated Aug 17, 2022.